1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Mania: new trials by email Literature Review of Mania trials Research Report on Mania
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features. Aripiprazole - Adolescent Schizophrenia, Child or Adolescent Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features | Phase 3 | Terminated | Otsuka Pharmaceutical Development & Commercialization, Inc. | 524 | 2010-07-01 | 2016-02-08 |
Schizophrenia (1)
Mental Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Signs and Symptoms (1)
Aripiprazole (1)
Otsuka Pharmaceutical Development & Commercialization, Inc. (1)
Bulgaria (1) · Croatia (1) · Hungary (1) · India (1) · Malaysia (1) · Philippines (1) · Poland (1) · Romania (1) · Russia (1) · Serbia (1) · Taiwan (1) · Ukraine (1) · United States (1)
Eva Kohegyi, MD (1)